Cargando…

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

BACKGROUND: The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement. METHODS: This prospective observational study included 1436 patients with refractory allergic conju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Atsuki, Ohashi, Yuichi, Ebihara, Nobuyuki, Uchio, Eiichi, Okamoto, Shigeki, Kumagai, Naoki, Shoji, Jun, Takamura, Etsuko, Nakagawa, Yayoi, Namba, Kenichi, Fujishima, Hiroshi, Miyazaki, Dai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112440/ https://www.ncbi.nlm.nih.gov/pubmed/24695688 http://dx.doi.org/10.1136/bjophthalmol-2013-304453

Ejemplares similares

Air pollution significantly associated with severe ocular allergic inflammatory diseases
por: Miyazaki, Dai, et al.
Publicado: (2019)

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Efficacy of Proactive Topical Antihistamine Use in Patients with Seasonal Allergic Conjunctivitis
por: Fukushima, Atsuki, et al.
Publicado: (2022)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial
por: Fukushima, Atsuki, et al.
Publicado: (2014)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
por: Yanai, Kaori, et al.
Publicado: (2013)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension
por: Fujishima, Hiroshi, et al.
Publicado: (2020)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease
por: Rice, Shantini A, et al.
Publicado: (2013)

Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015)

EFFECT OF 0.1% TACROLIMUS OINTMENT IN LOCALIZED VITILIGO: AN OPEN UNCONTROLLED TRIAL
por: Bhuvana, K, et al.
Publicado: (2011)

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
por: Albarry, Maan Abdullah, et al.
Publicado: (2022)

Case of immunotactoid glomerulopathy showing high responsiveness to steroids therapy despite severe pathological features
por: Ohashi, Atsuki, et al.
Publicado: (2019)

Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2016)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Adhesion of Pollen Particles to Daily Disposable Soft Contact Lenses
por: Mimura, Tatsuya, et al.
Publicado: (2021)

The Use of Topical Tacrolimus 0.1% Skin Ointment for Anterior Segment Conditions: A Case Series
por: Abeysiri, Poorna, et al.
Publicado: (2010)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012)

Comparison of topical clobetasol propionate 0.05% and topical tacrolimus 0.1% in the treatment of cutaneous lichen planus
por: Özkur, Ezgi, et al.
Publicado: (2020)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Retinal Features of Family Members With Familial Exudative Vitreoretinopathy Caused By Mutations in KIF11 Gene
por: Kondo, Hiroyuki, et al.
Publicado: (2021)

Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure
por: Kasai, Hiroko, et al.
Publicado: (2021)

To estimate the efficacy of 0.1% tacrolimus with Colgate Oraguard-B paste for the treatment of patients with symptomatic oral lichen planus
por: Nisa, Shams Ul, et al.
Publicado: (2016)

Tacrolimus dye drop treatment for the management of early post-operative intraocular inflammation after therapeutic keratoplasty for severe infectious keratitis
por: Zang, Yunxiao, et al.
Publicado: (2020)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Development of In Vitro Dry Eye Models to Study Proliferative and Anti-Inflammatory Effects of Allogeneic Serum Eye Drops
por: Voß, Silja, et al.
Publicado: (2023)

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Patil, Ankita A, et al.
Publicado: (2022)

IM-01 PI3K GAMMA INHIBITOR FOR OVERCOMING TREATMENT RESISTANCE IN COMBINATION THERAPY OF TEMOZOLOMIDE AND ANTI-PDL1 ANTIBODY FOR GLIOBLASTOMA PATIENTS
por: Ishikawa, Eiichi, et al.
Publicado: (2019)

Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2011)

Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods
por: Uchio, Eiichi, et al.
Publicado: (2010)

Anti-adenoviral Effects of Human Cationic Antimicrobial Protein-18/LL-37, an Antimicrobial Peptide, by Quantitative Polymerase Chain Reaction
por: Uchio, Eiichi, et al.
Publicado: (2013)

Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods
por: Huang, Jane, et al.
Publicado: (2014)

Simulation of airbag impact on eyes with different axial lengths after transsclerally fixated posterior chamber intraocular lens by using finite element analysis
por: Huang, Jane, et al.
Publicado: (2015)

Clinical and allergological analysis of ocular manifestations of sick building syndrome
por: Saeki, Yusuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l9oqtraq6fmjs27sicu1cvjhpc